These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results]. Tourneur R, Letonturier P, Sénécal P. Minerva Med; 1974 Mar 14; 65(19):995-8. PubMed ID: 4406464 [No Abstract] [Full Text] [Related]
7. [Autoimmunization symptoms in thyroid diseases]. Wegier A, Głab S, Wróblewska I, Nowak M, Feluś E. Pol Tyg Lek; 1978 Dec 25; 33(52):2011-3. PubMed ID: 366580 [No Abstract] [Full Text] [Related]
8. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983. Munro DS. J R Coll Physicians Lond; 1984 Jul 25; 18(3):155-60. PubMed ID: 6147408 [No Abstract] [Full Text] [Related]
9. Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease. Hardisty CA, Munro DS. Br Med J (Clin Res Ed); 1983 Mar 19; 286(6369):934-5. PubMed ID: 6403139 [Abstract] [Full Text] [Related]
10. Indirect immunofluorescence and generation of cyclic-AMP investigation with Graves' patients' sera. Szabó J, Fórizs E, Szabó T, Leövey A. Acta Med Hung; 1986 Mar 19; 43(3):275-81. PubMed ID: 3035480 [Abstract] [Full Text] [Related]
11. [Human thyroid stimulator (HTS) in thyroid diseases]. Hu ZY. Zhonghua Nei Ke Za Zhi; 1984 Aug 19; 23(8):480-3, 525. PubMed ID: 6548953 [No Abstract] [Full Text] [Related]
12. The prediction of relapse after drug treatment of Graves' disease by assay of long acting thyroid stimulator-protector (LATS-P). Hardisty CA, Hanford L, Munro DS. Clin Endocrinol (Oxf); 1981 May 19; 14(5):509-17. PubMed ID: 6895487 [Abstract] [Full Text] [Related]
13. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies. Knight A, Adams DD. Clin Exp Immunol; 1983 May 19; 52(2):317-24. PubMed ID: 6134598 [Abstract] [Full Text] [Related]
14. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy. Földes J, Takó J, Bános C, Gesztesi E. Acta Med Acad Sci Hung; 1971 May 19; 28(2):171-9. PubMed ID: 5172524 [No Abstract] [Full Text] [Related]
16. [LATS and other antibodies against the TSH receptor]. Rodríguez Zapata MM. Med Clin (Barc); 1983 Feb 19; 80(4):177-81. PubMed ID: 6134881 [No Abstract] [Full Text] [Related]
17. The effect of radioiodine and antithyroid drugs on serum long acting thyroid stimulator protector (IATS-P). A three year prospective study. Hardisty CA, Fowles A, Munro DS. Clin Endocrinol (Oxf); 1984 May 19; 20(5):597-605. PubMed ID: 6547647 [Abstract] [Full Text] [Related]
18. The long-acting thyroid stimulator. Munro DS. Sci Basis Med Annu Rev; 1970 May 19; ():21-30. PubMed ID: 4920180 [No Abstract] [Full Text] [Related]
19. The spectrum and significance of autoantibodies reacting with the thyrotropin receptor. Zakarija M, McKenzie JM. Endocrinol Metab Clin North Am; 1987 Jun 19; 16(2):343-63. PubMed ID: 3319587 [Abstract] [Full Text] [Related]
20. [Thyroid stimulating immunoglobulins, their role and significance in the pathogenesis of Basedow-Graves disease]. Leövey A. Orv Hetil; 1978 Aug 13; 119(33):2019-21. PubMed ID: 209384 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]